Growth Metrics

Omeros (OMER) Shareholder's Equity (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 47.76%
Dec 31, 2025 45.01%
Sep 30, 2025 3.59%
Jun 30, 2025 -7.09%
Mar 31, 2025 -16.95%
Dec 31, 2024 -18.44%
Sep 30, 2024 -23.74%
Jun 30, 2024 -74.68%
Mar 31, 2024 -185.51%
Dec 31, 2023 -79.06%
Sep 30, 2023 -168.03%
Jun 30, 2023 -62.67%
Mar 31, 2023 -35.89%
Dec 31, 2022 285.01%
Sep 30, 2022 -41.62%
Jun 30, 2022 -564.00%
Mar 31, 2022 -120.71%
Dec 31, 2021 109.05%
Sep 30, 2021 -6.66%
Jun 30, 2021 -10.97%
Mar 31, 2021 -83.81%
Dec 31, 2020 -38.28%
Sep 30, 2020 45.85%
Jun 30, 2020 -22.30%
Mar 31, 2020 -20.95%
Dec 31, 2019 22.08%
Sep 30, 2019 -7.40%
Jun 30, 2019 -7.65%
Mar 31, 2019 -20.83%
Dec 31, 2018 -12.54%
Sep 30, 2018 -58.08%
Jun 30, 2018 -92.70%
Mar 31, 2018 -938.20%
Dec 31, 2017 -130.55%
Sep 30, 2017 116.79%
Jun 30, 2017 -14.00%
Mar 31, 2017 -28.48%
Dec 31, 2016 -64.44%
Sep 30, 2016 53.52%
Jun 30, 2016 -20.26%
Mar 31, 2016 -55.30%
Dec 31, 2015 -191.36%
Sep 30, 2015 -213.51%
Jun 30, 2015 -63.69%
Mar 31, 2015 151.22%
Dec 31, 2014 -60.42%
Sep 30, 2014 -150.58%
Jun 30, 2014 -303.59%
Mar 31, 2014 128.35%
Dec 31, 2013 23.06%
Sep 30, 2013 -94.95%
Jun 30, 2013 22.74%
Mar 31, 2013 -142.90%
Dec 31, 2012 -696.46%
Sep 30, 2012 96.01%
Jun 30, 2012 -61.93%
Mar 31, 2012 -128.36%
Dec 31, 2011 -236.23%
Sep 30, 2011 -59.29%